Page 199 - product-manual
P. 199

TM/MC  TM/MC
             PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





                               Calcium (Citrate)

                               Calcium is a major structural element in bones and teeth. The amount of calcium absorption in
                               dogs ranges from 25 to 90 percent, depending on the amount of intake and the age of the animal
                               (Ettinger & Feldman, 2000a). Calcium deficiency in dogs is characterized by rickets in normal
                               dogs, milk fever syndrome in pregnant or lactating dogs and a condition known as nutritional
                               secondary  hyperparathyroidism  (NSHP).  Chronic  dietary  calcium  deficiency  causes  major
                               decreases in bone material content, which can result in significant skeletal abnormalities including
                               fractures. Calcium intake is tied directly to the calcium-phosphorus ratio (1.5:1) in the body. A
                               diet high in calcium and low in phosphorus may lead to problems metabolizing the calcium. It
                               will cause bone deformities and hip dysplasia. Calcium deficiency in kittens demonstrated bone
                               rarefaction, especially in the lumbar vertebrae which tended to curve and collapse, and in the
                               pelvis (NRC, 2006).




            TOXICOLOGY  Toxicity for calcium citrate has not been documented in dogs and cats when administered orally in therapeutic
                 doses. LD  of calcium citrate is not documented. Oral LD  for calcium carbonate is 6,450 mg/kg of body
                         50
                                                                  50
                 weight in rats (Sciencelab, 2010a).





                   DRUG    Significant  interactions  have  been  observed  between  calcium  and  certain  antibiotics  namely
          INTERACTIONS     tetracyclines and fluoroquinolones (Pfizer, 1990; Bayer, 2002). Calcium decreases the bioavailability
                           of levothyroxine (Abbott, 2002). Combining calcium with thiazide diuretics increases the risk of
                           developing hypercalcemia. High doses of supplemental calcium could increase the likelihood of
                           abnormal heart rhythms in people taking digitalis for heart failure (Vella et al., 1999). Intravenous
                           calcium salts can prevent hypotension associated with intravenous verapamil (Moser et al., 2000).
                           Calcium citrate when taken with aluminum-containing antacids, the amount of aluminum absorbed
                           into the blood may be increased significantly. Bile acid sequestrants such as cholestyramine, colestipol,
                           and colesevelam may interfere with calcium absorption and increase the loss of calcium in the urine
                           (UMMC, 2012f).
























        14 |   VimForte -VM TM
   194   195   196   197   198   199   200   201   202   203   204